Related Experiment Video
Updated: Aug 16, 2026
Methods to Study Changes in Inherent Protein Aggregation with Age in Caenorhabditis elegans
Published on: November 26, 2017
RalGDS comes of age
Pablo Rodriguez-Viciana1, Frank McCormick
1University of California, San Francisco, Cancer Research Institute, 2340 Sutter Street, San Francisco, California, 94115, USA.
Abstract:
Ras proteins send signals through multiple effector pathways. The Raf/MEK/MAPK and PI 3' kinase pathways are well-validated Ras effectors in human cancers, but many other candidate pathways could be equally important. RalGDS is such a candidate: in a new paper from Chris Marshall's group, an important role for RalGDS in Ras transformation in vivo has been established for the first time. Mice lacking RalGDS are defective in tumor formation, possibly because of increased apoptosis in Ras-driven tumors. The hunt for a clear role for RalGDS activation in human cancer is on.
Insights
Ral guanine nucleotide exchange factor (RalGDS) is crucial for Ras-driven tumor formation in mice. RalGDS-deficient mice show reduced tumor development, potentially due to increased apoptosis in Ras-activated tumors.
Area of Science:
- Oncology
- Molecular Biology
- Signal Transduction
Background:
- Ras proteins are key regulators of cellular signaling pathways implicated in human cancers.
- While Raf/MEK/MAPK and PI 3' kinase are established Ras effectors, other pathways remain less understood.
- Ral guanine nucleotide exchange factor (RalGDS) has been investigated as a potential Ras effector pathway.
Discussion:
- This study establishes a critical role for RalGDS in Ras-mediated tumorigenesis in vivo for the first time.
- Mice lacking RalGDS exhibit impaired tumor formation, suggesting RalGDS is essential for Ras-driven cancer progression.
- The mechanism may involve increased apoptosis in tumors lacking RalGDS, indicating a pro-survival role for this pathway.
Key Insights:
- RalGDS is a significant effector of Ras signaling in the context of cancer development.
- Loss of RalGDS function compromises the ability of Ras to drive tumor formation in vivo.
- Apoptosis regulation is a key aspect of RalGDS's function in Ras-driven oncogenesis.
Outlook:
- Further research is needed to elucidate the precise mechanisms by which RalGDS influences apoptosis.
- Investigating RalGDS activation in human cancers will clarify its therapeutic potential.
- Targeting the RalGDS pathway could offer novel strategies for cancer treatment.
